Reduction of metformin renal tubular secretion by cimetidine in man
- PMID: 3593625
- PMCID: PMC1386190
- DOI: 10.1111/j.1365-2125.1987.tb03090.x
Reduction of metformin renal tubular secretion by cimetidine in man
Abstract
To determine whether cimetidine altered the renal handling of metformin, seven subjects took 0.25 g metformin daily with and without cimetidine 0.4 g twice daily. Blood and urine samples were collected and assayed for metformin, cimetidine and creatinine by h.p.l.c. Cimetidine significantly increased the area under the plasma metformin concentration-time curve by an average of 50% and reduced its renal clearance over 24 h by 27% (P less than 0.008). There was no alteration in the total urinary recovery of metformin when cimetidine was co-administered. The effect of cimetidine on the renal clearance of metformin was time dependent, being significantly reduced up to 6 h following cimetidine. These results appeared to be consistent with competitive inhibition of renal tubular secretion. Cimetidine had no effect on the renal clearance of creatinine, but time-dependent variations in both metformin and creatinine renal clearance were observed. Metformin had no effect on cimetidine disposition. It is concluded that cimetidine inhibits the renal tubular secretion of metformin in man, resulting in higher circulating plasma concentrations. Because of its propensity for causing dose and concentration-dependent adverse effects, the dose of metformin should be reduced when cimetidine is co-prescribed.
Similar articles
-
Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs.Eur J Clin Pharmacol. 1983;25(3):339-45. doi: 10.1007/BF01037945. Eur J Clin Pharmacol. 1983. PMID: 6194997
-
Renal tubular transport of cimetidine in the isolated perfused kidney of the rat.Drug Metab Dispos. 1994 Jan-Feb;22(1):148-53. Drug Metab Dispos. 1994. PMID: 8149875
-
Evaluation of the potential interaction between tofacitinib and drugs that undergo renal tubular secretion using metformin, an in vivo marker of renal organic cation transporter 2.Clin Pharmacol Drug Dev. 2014 Nov;3(6):499-507. doi: 10.1002/cpdd.120. Epub 2014 May 23. Clin Pharmacol Drug Dev. 2014. PMID: 27129125 Clinical Trial.
-
Renal tubular secretion of amiloride and its inhibition by cimetidine in humans and in an animal model.Drug Metab Dispos. 1989 Mar-Apr;17(2):190-6. Drug Metab Dispos. 1989. PMID: 2565210 Clinical Trial.
-
Renal interaction between itraconazole and cimetidine.J Clin Pharmacol. 2004 Aug;44(8):919-27. doi: 10.1177/0091270004266783. J Clin Pharmacol. 2004. PMID: 15286096 Clinical Trial.
Cited by
-
A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators.Pharmaceutics. 2021 May 11;13(5):698. doi: 10.3390/pharmaceutics13050698. Pharmaceutics. 2021. PMID: 34064886 Free PMC article.
-
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.Br J Pharmacol. 2011 Dec;164(7):1817-25. doi: 10.1111/j.1476-5381.2011.01394.x. Br J Pharmacol. 2011. PMID: 21457222 Free PMC article. Review.
-
Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters.Cancer Res. 2010 Jul 15;70(14):5931-41. doi: 10.1158/0008-5472.CAN-10-0694. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551056 Free PMC article.
-
A Two-Period Open-Label, Single-Dose Crossover Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Between Cimetidine and Inhaled Extrafine CHF 5993.Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):269-279. doi: 10.1007/s13318-016-0345-2. Eur J Drug Metab Pharmacokinet. 2017. PMID: 27209586 Free PMC article. Clinical Trial.
-
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin.Pharmacogenet Genomics. 2010 Nov;20(11):687-99. doi: 10.1097/FPC.0b013e32833fe789. Pharmacogenet Genomics. 2010. PMID: 20859243 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources